
Ultra-minimum incision personalized intratumoral chemoimmunotherapy inopa nzira yakanangwa yekurapa cancer, kuderedza kupindira uku uchiwedzera kurapa kwakanaka. Iyi nzira yekuvandudza inosanganisa kurongeka kwekuvhiyiwa kusinganyanyi kupindira nesimba remushonga wega wega uye immunotherapy, zvichitungamira kukuvandudzwa kwemhedzisiro yemurwere uye kuderedzwa kwemhedzisiro. Dzidza zvakawanda pamusoro peiyi danho rekusimudzira mukutarisira cancer.
Kuvhiyiwa kwegomarara kwechinyakare kunowanzo sanganisira kuchekwa kukuru, zvichiita kuti nguva yakawedzerwa yekupora uye mavanga makuru. Kuvhiya kwe Ultra-minimum incision kunoshandisa zviridzwa zvemberi zvekuvhiya uye matekiniki ekuita maitiro kuburikidza nediki diki. Izvi zvinoderedza kukuvara kwetishu, zvichikonzera kurwadziwa kushoma, kukurumidza kupora, uye kuvandudzwa kwezvizoro. Mamiriro chaiwo emaitirwo aya anobvumira vavhiyi kuti vanyatso kunanga bundu uku vachichengetedza hutano hwakatenderedza.
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy inoziva iyo yakasiana yemajini uye mamorekuru maitiro ebundu remurwere wega wega. Nekuongorora hunhu uhwu, oncologists vanogona kugadzira hurongwa hwekurapa hwemunhu hunonangana nemaseru egomarara uku vachichengetedza maseru ane hutano. Iyi nzira yemunhu inowedzera kushanda kwekurapa uye inoderedza njodzi yezvinokuvadza zvichienzaniswa neyechinyakare, imwe-saizi-inokodzera-ese nzira.
Kutungamirirwa kwechemotherapy uye immunotherapy zvakananga mubundu (intratumoral delivery) inova nechokwadi chokuti huwandu hwepamusoro hwemishonga hunosvika kune chinangwa, kuwedzera kushanda kwayo. Iyi nzira yakanangwa inoderedza kuratidzwa kwemaitiro kumishonga, kuderedza mukana wemhedzisiro yakaipa mumuviri wese. Nzira dzakasiyana dzekuburitsa dzinogona kushandiswa zvichienderana nerudzi rwegomarara uye nzvimbo yebundu. Tsvagiridzo iri kuramba ichifambira mberi mundima iyi, ichitsvaga nzira nyowani uye dzinoshanda dzekuunza intratumoral zvinodhaka.
Iri zano rekurapa rinosanganisa iyo cytotoxic mhedzisiro yechemotherapy neiyo immune-inowedzera kugona kwe immunotherapy. Chemotherapy inouraya zvakananga maseru egomarara, nepo immunotherapy ichibatsira immune system yemuviri kuziva nekuparadza maseru egomarara zvakanyanya. Iko kusanganiswa kweaya maviri ekurapa ane simba kunogadzira synergistic mhedzisiro, kazhinji inotungamira kune yakavandudzwa mhinduro mazinga uye kuregererwa kwenguva refu.
Zvakanakira Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy zvinosanganisira:
Zvidzidzo zvakawanda zvekutsvagisa uye zviyedzo zvekiriniki zviri kuitika pari zvino kuenderera mberi nekuongorora kushanda uye kuchengetedzeka kwe Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy pamhando dzakasiyana dzegomarara. Zvidzidzo izvi zviri kupa ruzivo rwakakosha mumaitiro akakwana ekurapa uye maitiro ekusarudza murwere. Nezvezvichangobva kuwanikwa patsvagiridzo, zvinokurudzirwa kubvunza majenari ezvekurapa anoongororwa nevezera rako uye nemasangano ane mukurumbira wekutsvagisa cancer. The Shandong Baofa Cancer Research Institute ari kushingairira kuita tsvakiridzo irikuenderera mberi iyi.
Ndichiri kuvimbisa, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy haina matambudziko anogona kuitika. Izvi zvinosanganisira kudiwa kwehunyanzvi hwekuvhiya nemidziyo, kuoma kwekuronga kurapwa kwemunhu, uye mukana wezvinetswa zvisingatarisirwi. Kumwe kutsvagurudza kwakakosha kugadzirisa matambudziko aya uye kuwedzera mashandisirwo eiyi nzira itsva yekurapa. The Shandong Baofa Cancer Research Institute yakazvipira kusimudzira ruzivo nekushandiswa kwekurapa uku.
p>
parutivi>
body>